Why Microbot Medical Inc.’s (MBOT) Stock Is Down 41.45%
As of Monday, November 16, Microbot Medical Inc.’s MBOT share price has dipped by 41.45%, which has investors questioning if this is right time to buy.Jenna Brashear
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Michael Rose
Tudor Pop
Jenna Brashear
Tudor Pop
| Share Statistics | MBOT | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $46.3 | $372.7 | 17% |
|
| Shares Out (Mil) | 67.2 | 41.4 | 54% |
|
| Institutional Ownership | na | 84.0% | na |
|
| Float (Mil) | 67.2 | 35.6 | 53% |
|
| Beta | na | 0.87 | na |
|
| Avg Daily Volume (000s) | 1,969 | 323 | 79% |
|
| Price Change (52-week) |
(66.7%) | 57.5% | 14% |
|
| Growth | MBOT | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.8% | na |
|
| Net Income (5yr) | (7.3%) | (5.7%) | 32% |
|
| EPS (5yr) | 25.9% | 10.6% | 77 |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | 15.0% | (15.8%) | 73% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 2 | 4 | |
| Current EPS | ($0.100) | ($0.325) | ($0.343) | |
| Month Ago EPS | ($0.083) | ($0.300) | ($0.303) | |
| # Rev Up | 1 | 1 | 1 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | ($0.100) | ($0.325) | ($0.333) | |
| Year/Year Chg | 11.1% | 13.2% | (10.5%) | |
| Financials | MBOT | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $0 | $125 | 1% |
|
| Net Income (TTM) (Mil) | ($19) | ($9) | 24% |
|
| EPS (TTM) | ($0.277) | ($0.300) | 31% |
|
| Operating Cash Flow (TTM) (Mil) | ($19) | ($1) | 15% |
|
| Net Cash Flow (TTM) (Mil) | na | $2 | na |
|
| Long-Term Debt (Q1) (Mil) | $1 | $21 | 14% |
|
| Enterprise Value (Q1) (Mil) | $5 | $381 | 6% |
|
| Valuation | MBOT | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.73 | 2.58 | 18% |
|
| P/E | na | 25.8 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.3 | na |
|
| Ratios | MBOT | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | (398.3%) | 59.5% | 0% |
|
| Net Margin | na | (4.5%) | na |
|
| ROA | (24.8%) | (10.1%) | 18% |
|
| ROE | (26.3%) | (8.3%) | 21% |
|
| Liabilities to Assets | 7.0% | 45.8% | 4% |
|
| F-Score | 2 | 4 | 7% |
|
Microbot Medical Inc. did not pass any screens on 11/17/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors